1 – 10 of 20
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2017
-
Mark
Low Rates of Transmitted Drug Resistance Among Newly Identified HIV-1 Seroconverters in Rural Rakai, Uganda
(
- Contribution to journal › Article
- 2015
-
Mark
Co-circulation of several similar but unique HIV-1 recombinant forms in Guinea-Bissau revealed by near full-length genomic sequencing.
(
- Contribution to journal › Article
- 2013
-
Mark
Frequent intratype neutralization by plasma immunoglobulin A identified in HIV-2 infection.
(
- Contribution to journal › Article
-
Mark
Short communication : HIV type 1 transmitted drug resistance and evidence of transmission clusters among recently infected antiretroviral-naive individuals from Ugandan fishing communities of Lake Victoria
(
- Contribution to journal › Article
- 2010
-
Mark
Differential Effects of Efavirenz, Lopinavir/r, and Atazanavir/r on the Initial Viral Decay Rate in Treatment Naive HIV-1-Infected Patients
(
- Contribution to journal › Article
-
Mark
Increased sensitivity to neutralizing antibodies of end-stage disease R5 HIV-1 is concomitant with reduced gp120 glycosylation and increased plus charge
(
- Contribution to journal › Published meeting abstract
- 2009
-
Mark
Mode of Coreceptor Use by R5 HIV Type 1 Correlates with Disease Stage: A Study of Paired Plasma and Cerebrospinal Fluid Isolates.
(
- Contribution to journal › Article
- 2008
-
Mark
Standardization of HIV Neutralization Assays for Use in Vaccine Research and Clinical Trials: Results from the NeutNet Working Group
(
- Contribution to journal › Published meeting abstract
-
Mark
Sensitivity of HIV-1 primary isolates to human anti-CD40 antibody-mediated suppression is related to co-receptor use
(
- Contribution to journal › Article
-
Mark
Global HIV Vaccine Research Cryorepository - GHRC
(
- Contribution to journal › Published meeting abstract